Magnesia sulphurica

MAGNESIUM SULFATE HEPTAHYDRATE ORAL HUMAN OTC DRUG

Magnesia sulphurica is an FDA drug label for the active ingredient MAGNESIUM SULFATE HEPTAHYDRATE manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231114.

Generic name
MAGNESIUM SULFATE HEPTAHYDRATE
Manufacturer
Boiron
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
0220-3267
Application
N/A
Label effective
20231114

Active ingredients

Magnesia sulphurica 30C (**contains 0.443 mg of the active ingredient per pellet)

Indications & Usage

Irritability or itchy skin rash*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.

More products with the same ingredient

MAGNESIUM SULFATE HEPTAHYDRATE

MAGNESIUM SULFATE

Gland Pharma Limited View label

Magnesium Sulfate

Medical Purchasing Solutions, LLC View label

Magnesium Sulfate

Medical Purchasing Solutions, LLC View label

Magnesium Sulfate

Sagent Pharmaceuticals View label

Magnesium Sulfate

Fresenius Kabi USA, LLC View label

PHUEL

AVADIM HOLDINGS, INC. View label

PHUEL

AVADIM HOLDINGS, INC. View label